Core Points - The company N建发致 was listed today with an opening price of 36.00 yuan, reflecting a significant increase of 410.64% from its issue price [2] - The company primarily engages in the direct sales and distribution of medical devices and provides centralized operation services for medical consumables to hospitals [2] - The total number of shares issued by the company is 63.19 million, with an online issuance of 20.85 million shares at an issue price of 7.05 yuan per share, resulting in a price-to-earnings ratio of 13.29, which is lower than the industry average of 25.73 [2] - The effective subscription number for the online issuance reached 13.47 million accounts, with a final winning rate of approximately 0.0198% [2] - The funds raised from the initial public offering (IPO) amount to 446 million yuan, which will be allocated to enhance working capital, upgrade information systems, and support centralized operation services for medical consumables [2] Recent IPO Performance - N建发致 (301584) was listed on September 25, 2025, with an issue price of 7.05 yuan and a first-day opening increase of 410.64% in the pharmaceutical and biological industry [2] - Other recent IPOs on the same day include N联合动 (301656) with a first-day increase of 174.04% and N锦华 (920015) with a first-day increase of 114.88%, indicating strong market interest in new listings [2][3] - The performance of newly listed stocks shows significant first-day price increases across various sectors, highlighting a trend of investor enthusiasm for IPOs [2][3]
N建发致上市首日开盘上涨410.64%